- Home
- / Tianjin Tianyao Pharmaceutical
Tianjin Tianyao Pharmaceutical
Stock Price
¥4.3
2024-10-29
Market Capitalization
¥4.7 B
2024-10-29
Revenue
¥3.1 B
FY, 2024
Tianjin Tianyao Pharmaceutical Summary
Company Summary
- Overview
- Tianjin Tianyao Pharmaceutical (天津天药药业股份有限公司) is a company that manufactures injection products. Its drugs include dexamethasone, dexamethasone sodium phosphate, dexamethasone acetate, triamcinolone, etc.
- Type
- Public
- Status
- Active
- Founded
- 1939
- HQ
- CN | view all locations
- Website
- http://www.tjpcty.com
- Cybersecurity rating
Table of Contents
LocationsView all
1 location detected
Tian Jin Shi HQ
China
Ba Wei Lu, He Dong Qu
Tianjin Tianyao Pharmaceutical Financials
Summary Financials
- Revenue (Q3, 2025)
- ¥642.6M
- Gross profit (Q3, 2025)
- ¥237.4M
- Net income (Q3, 2025)
- ¥27.9M
- Cash (Q3, 2025)
- ¥643.8M
- EBIT (Q3, 2025)
- ¥33.0M
- Enterprise value
- $4.8B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026